Journal of the American Chemical Society · 2023 · 41 citations · 31 references
MedicineBioengineeringBiomedical EngineeringBiomedical ImagingDiagnostic ImagingMolecular ImagingCellular ImagingMagnetic Resonance ImagingMagnetic Resonance Imaging PhysicsMagnetic Resonance Molecular ImagingMedical ImagingMolecular Probe DevelopmentContrastGene Expression ReportersMagnetic ResonanceMagnetic Resonance Imaging Contrast AgentsMagnetic Resonance PhysicsMolecular Contrast AgentsMolecular Imaging ProbesResponsive Mri Probes
Real-time detection of bio-event in whole animals provides essential information for understanding biological and therapeutic processes. Magnetic resonance (MR) imaging represents a non-invasive approach to generating three-dimensional anatomic images with high spatial–temporal resolution and unlimited depth penetration. We have developed several self-immolative enzyme-activatable agents that provide excellent in vivo contrast and function as gene expression reporters. Here, we describe a vast improvement in image contrast over our previous generations of these bioresponsive agents based on a new pyridyl-carbamate Gd(III) complex. The pyridyl-carbamate-based agent has a very low MR relaxivity in the “off-state” ( r 1 = 1.8 mM –1 s –1 at 1.41 T). However, upon enzymatic processing, it generates a significantly higher relaxivity with a Δ r 1 = 106% versus Δ r 1 ∼ 20% reported previously. Single X-ray crystal and nuclear magnetic relaxation dispersion analyses offer mechanistic insights regarding MR signal enhancement at the molecular scale. This work demonstrates a pyridyl-carbamate-based self-immolative molecular platform for the construction of enzymatic bio-responsive MR agents, which can be adapted to a wide range of other targets for exploring stimuli-responsive materials and biomedical applications.
31